BiOptix and Altermune Technologies Present at Drug Analysis 2014

Boulder, Colorado / Irvine, California / Liege, Belgium June 26, 2014 – BiOptix, in conjunction with Altermune Technologies announced today the presentation of a poster for “Quantitative SPR Screening of Aptamer-Protein Interactions for Pre-Clinical Development” at the Drug Analysis 2014 meeting in Liege, Belgium.

Details

BiOptix Continues California Roadshow Highlighting New Publication Data

Boulder, Colorado / San Francisco, California, February 18, 2014 – With its participation in the 58th annual Biophysical Society Meeting from February 15 – 19, along with the 21st International Molecular Medicine Tri-Conference, BiOptix entered a second week highlighting the 404pi SPR platform and new publication data to a global research audience in California.

Details

BiOptix Continues Support of Antibody Engineering & Therapeutics Research

Boulder, Colorado and Huntington Beach, CA, December 11, 2013 /PRNewswire/ — BiOptix continues support of the global antibody engineering and therapeutics research community through participation in IBC’s 24th Annual Antibody Engineering & Therapeutics Conference and annual meeting of The Antibody Society, being held in Huntington Beach, CA from December 8 – 12, 2013.

Details

BiOptix Presents New and Compelling Kinetics Data in the Fight Against Cancer

Boulder, Colorado/Washington, DC, April 8, 2013 /PRNewswire/ — BiOptix will present new and compelling PSA (Prostate-Specific Antigen) data from the BiOptix 404pi, the first commercially available SPR instrument to incorporate phase-based common path interferometry technology at the annual American Association for Cancer Research (AACR) meeting in Washington D.C., which is being held from April 6-10, 2013.

Details

BiOptix Announces a New SPR Technology for Antibody Manufacturers and Researchers

Boulder, Colorado/San Diego, CA, December 3, 2012 /PRNewswire/ — BiOptix announced today that it will be showcasing the new BiOptix 404pi at IBC’s 23rd Annual Antibody Engineering and Therapeutics Conference in San Diego. The conference, which runs December 2 – 6, 2012, is one of the preeminent technology symposia in the world for the international antibody development and research community.

Details

BiOptix to Highlight New 404pi Instrument at European Symposia

Boulder, Colorado/Amsterdam, The Netherlands/Vienna, Austria, November 1, 2012 /PRNewswire/ — BiOptix today announced that it would be highlighting the new BiOptix 404pi, the first commercially available SPR instrument to incorporate phase-based common path interferometry technology, at the Label Free Technologies Show in Amsterdam from November 1 – 3 as well as at the PEGS Europe Summit on November 6 – 8.

Details